IMAGINIS.COM BREAST HEALTH NEWSLETTER
VOLUME 3, ISSUE 12
MARCH 29, 2001
WOMEN'S HEALTH NEWS AND INFORMATION
1. NO NEED FOR WOMEN TO TAKE TAMOXIFEN LONGER THAN FIVE YEARS, STUDY FINDS
Scottish researchers have found that women get the maximum benefit from the drug tamoxifen
(brand name, Nolvadex) by taking it for a period of five years-no longer, no
shorter. Tamoxifen has been used for over 20 years to treat advanced breast cancer, and in
1998, it became the first drug approved by the U.S. Food and Drug Administration (FDA) to
help prevent breast cancer in women at high risk of the disease. Why is five years the
ideal time period for tamoxifen?
Click here to read more:
http://www.imaginis.com/breasthealth/news/news3.27.01.asp
2. LARGE STUDY FINDS PROLONGED USE OF ESTROGEN REPLACEMENT THERAPY INCREASES RISK OF DEATH
FROM OVARIAN CANCER
In a study of more than 200,000 women, researchers from the American Cancer Society found
that using estrogen replacement therapy (ERT) for 10 or more years increases the risk of
death from ovarian cancer. While the chances of developing ovarian cancer doubles
with prolonged ERT use, the risk still appears to be small-approximately 2% over a
lifetime. Here's what women who are taking ERT (or considering ERT) should know...
Click here to read more:
http://www.imaginis.com/ovarian-cancer/news/news3.22.01.asp
3. CAN BREAST CANCER BE PREVENTED?
Scientists do not yet know what causes breast cancer, and consequently, there are no
general guidelines that women can follow to prevent the disease. Therefore, the most
practical strategy for most women is to reduce the controllable risk factors for breast
cancer and follow the screening guidelines set forth by the American Cancer Society and
other organizations to help detect breast cancer in its earliest stages when the chances
for successful treatment and survival are the greatest. For eligible women at especially
high risk of breast cancer, there a number of options that may help prevent breast cancer,
including tamoxifen, participation in a national breast cancer prevention trial (STAR),
preventive breast removal (prophylactic mastectomy), or in rare cases, preventive ovary
removal (oophorectomy). This article provides an overview of breast cancer preventive
options for women at especially high risk for the disease.
Click here to read more:
http://www.imaginis.com/breasthealth/preventive.asp
4. UNDERSTANDING NIPPLE DISCHARGE
Nipple discharge is the third most common breast complaint for which women seek medical
attention, after lumps and breast pain. The majority of nipple discharges are associated
with non-malignant changes in the breast such as hormonal imbalances. However, nipple
discharge may be a concern if it has certain characteristics. This article explains causes
of nipple discharge and when and how it should be evaluated and treated.
Click here to read more:
http://www.imaginis.com/breasthealth/nipple.asp
5. "CONFRONTING CANCER: IMAGES OF STRENGTH AND HOPE"
Photographer Gretje Fergusons exhibition, "Confronting Cancer: Images of
Strength and Hope," is appearing at Frame-It Studio and Gallery in Canton, MA from
April 3 to May 1, 2001. The public is invited to the opening on Thursday, April 5, from
5-7 p.m. Along with the photographer, several of the people photographed will speak
briefly about their cancer experiences. Ferguson is a black-and-white portrait
photographer based in Dedham, MA. The goal of the project is to show how people who are
facing a cancer diagnosis are living meaningful lives.
Click here to learn more or to view Ferguson's photographs online:
http://www.gfergphoto.com/confrontingcancer/
++++++++++++++++++++++++++++++++++++++++++++++++++++++++
BREAST CANCER DISCUSSION BOARD
"I have just been told that I have LCIS which was diagnosed through tissue examined
through a biopsy. The doctor's initial suggestion was to take tamoxifen. I am 52 years
old. Any feedback?"
Click here to visit this discussion:
http://www.imaginis.com/_private/ubb/Forum1/HTML/000412.html
Click here to post or reply to other messages on the Imaginis discussion boards:
http://www.imaginis.com/discussions/
++++++++++++++++++++++++++++++++++++++++++++++++++++++++
NEW IN THE IMAGINIS BOOKSTORE
"Reclaiming Our Lives After Breast and Gynecological Cancer" by Kristine Falco
is an unusually aware and supportive book that recognizes and addresses cancer's potential
assault on one's sense of self, femininity, and womanhood. It speaks with equal resonance
to women with (or who are worried about) cancer and to those who love them, as well as to
the professionals in mental, physical, and spiritual health who work with them. The author
of the book is a clinician who had breast cancer herself--twice.
Click here to learn more about this book:
http://www.imaginis.com/bookstore/breasthealth/survival.asp#reclaiming
Click here to browse nearly 150 books in the Imaginis Breast Health Bookstore:
http://www.imaginis.com/bookstore/
++++++++++++++++++++++++++++++++++++++++++++++++++++++++
ABOUT THIS NEWSLETTER
Thousands of breast cancer patients, survivors and healthcare professionals receive the
Imaginis.com Breast Health Newsletter, which is published by email every week. If you
enjoy receiving this newsletter, feel free to share it with a friend, colleague or family
member. Simply click "forward," type in a friend's email address, and then click
"send." If you would like to add the email addresses of your friends and family
to the newsletter mailing list, please visit http://www.imaginis.com/newsletter/
Please visit the Imaginis.com website at http://www.imaginis.com/
Imaginis.com is an independent, award-winning, comprehensive resource for news and
information on breast cancer prevention, screening, diagnosis, and treatment and related
women's health topics such as hormone replacement therapy (HRT), multiple sclerosis,
osteoporosis, and ovarian cancer. Imaginis.com breast health content is edited by an
expert breast imager and a breast surgeon. To learn more about the Imaginis.com Breast
Health Team and Editorial Board, please visit
http://www.imaginis.com/about/breast_health_team.asp
If you haven't already, please take a moment to send us your feedback! Your comments help
us tailor our website and newsletter to meet the needs of our readers. Click here to fill
out our online feedback form: http://www.imaginis.com/about/form.asp.
Or if you prefer, send us feedback by email at mailto:[email protected]
To view the full articles in this newsletter, click on the underlined links (web
addresses) following each summary. America Online (AOL) users may need to copy and paste
the links in this newsletter into a web browser to view them. In some cases, the links
following the summaries may not successfully retrieve the webpages if the address extends
to more than one line. If this occurs, please copy the full text of the link and paste it
into the address box in a web browser. Please note, Imaginis does not send
"spam" email and will unsubscribe anyone upon request (see link below).
++++++++++++++++++++++++++++++++++++++++++++++++++++++++
SIEMENS MEDICAL PROUDLY SPONSORS IMAGINIS.COM
To learn more about Siemens involvement in women's health, please visit http://www.imaginis.com/siemens/
++++++++++++++++++++++++++++++++++++++++++++++++++++++++
MEDICAL DISCLAIMER: INFORMATION IN THIS NEWSLETTER, WITHIN THE IMAGINIS.COM WEBSITE OR IN
OTHER SITES LINKED TO FROM THE IMAGINIS.COM WEBSITE SHOULD NOT BE USED FOR SELF-TREATMENT.
THE INFORMATION FOUND IN THIS NEWSLETTER, IN THE IMAGINIS.COM WEBSITE AND IN WEBSITES
LINKED TO FROM THE IMAGINIS.COM WEBSITE SHOULD BE USED FOR EDUCATIONAL PURPOSES ONLY AND
IS NOT INTENDED TO BE USED AS A SUBSTITUTE FOR DIAGNOSIS AND TREATMENT BY A MEDICAL
DOCTOR. USE OF THIS NEWSLETTER IS SUBJECT TO THE TERMS AND CONDITIONS OF USE FOUND ON
IMAGINIS.COM AT http://www.imaginis.com/guestbook/agreement.asp
. IMAGINIS.COM DOES NOT ENDORSE AND HAS NO RESPONSIBILITY FOR THE CONTENT OF ANY OTHER
SITES LISTED ON IMAGINIS.COM, AND PROVIDES LINKS AND REFERENCES MERELY AS A CONVENIENCE TO
ITS USERS. SEEK IMMEDIATE MEDICAL ATTENTION IF YOUR CONDITION IS URGENT.
Copyright © 2001, Imaginis Corporation. All rights reserved.
|
|